Voloridge Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-33,972
| Closed | -$384K | – | 1647 |
|
|
2022
Q1 | $384K | Buy |
+33,972
| New | +$384K | ﹤0.01% | 1240 |
|
|
2021
Q4 | – | Sell |
-39,634
| Closed | -$679K | – | 1869 |
|
|
2021
Q3 | $679K | Sell |
39,634
-61,468
| -61% | -$1.05M | ﹤0.01% | 1388 |
|
|
2021
Q2 | $2.18M | Sell |
101,102
-22,619
| -18% | -$487K | 0.02% | 968 |
|
|
2021
Q1 | $1.86M | Buy |
+123,721
| New | +$1.86M | 0.01% | 847 |
|
|
2020
Q4 | – | Sell |
-60,722
| Closed | -$587K | – | 1590 |
|
|
2020
Q3 | $587K | Buy |
60,722
+43,939
| +262% | +$425K | ﹤0.01% | 1062 |
|
|
2020
Q2 | $192K | Buy |
+16,783
| New | +$192K | ﹤0.01% | 1202 |
|
|
2019
Q4 | – | Sell |
-10,368
| Closed | -$138K | – | 1363 |
|
|
2019
Q3 | $138K | Sell |
10,368
-47,425
| -82% | -$631K | ﹤0.01% | 1007 |
|
|
2019
Q2 | $814K | Buy |
57,793
+8,310
| +17% | +$117K | 0.02% | 492 |
|
|
2019
Q1 | $910K | Buy |
+49,483
| New | +$910K | 0.03% | 507 |
|